- $1.10bn
- $5.11bn
- $2.46bn
Clarivate rises on $600 million deal to sell healthcare unit
Clarivate Q1 revenue and adjusted EPS beat estimates, reaffirms 2026 outlook
Clarivate Q4 revenue and EPS beat expectations, helped by subscription growth
Brief: Clarivate Announces Maroun S. Mourad As President, Intellectual Property
Brief: Clarivate Reports Second Quarter 2025 Results
Brief: Clarivate To Report Second Quarter 2025 Results On July 30, 2025
Brief: Clarivate Says Unit Issues Notice For $500 Million Partial Redemption Of Outstanding 4.50% Senior Secured Notes Due 2026 - SEC Filing
Brief: Clarivate Posts Q1 Adjusted Net Income $95.8 Mln Vs Ibes Estimate $80.8 Mln
Clarivate’s IP unit draws private equity interest, sources say
Brief: Clarivate Reports Third Quarter 2024 Results
Brief: Clarivate Removes Forward-Looking Outlook For 2024
Brief: Clarivate Appoints Former Proquest CEO Matti Shem Tov As The Company's Next CEO
Brief: Clarivate Acquires Rowan TELS To Enhance Support For Patent Practitioners
Brief: Clarivate PLC Acquires Global QMS, Expanding Life Sciences & Healthcare Segment Into New Markets
Brief: Clarivate Has Announced An Agreement To Acquire Substantial Majority Of Assets Of Motionhall
Astorg considers sale of IP software firm Anaqua, sources say
Astorg considers sale of IP software firm Anaqua, sources say
Exor takes 10% stake in data provider Clarivate, can rise to 17.5% (updated)
Exor announces 10% stake in data provider Clarivate, can rise to 17.5%